Welcome to Clinical Trials Advocacy Group for Prostate Cancer

Each year, hundreds of millions of dollars are spent in an effort to bring us closer to a cure for prostate cancer. Although treatment options have and continue to improve, this disease still takes the lives of too many our grandfathers, fathers, uncles, brothers and friends.

Prostate cancer clinical trials evaluate the benefits and risks of new drugs, combinations of drugs or other medical technologies that are meant to improve or lengthen the lives of men battling this disease. Prostate cancer clinical trials offer access to these new and promising treatment options, when otherwise, they might not be available.

Prostate cancer clinical trials are only discussed with about 12% of the men who are diagnosed with prostate cancer. Because of this, many seemingly promising new treatments fail to become approved for use. If you or someone you care about is facing prostate cancer, ask about the clinical trials that are available. If you are a doctor or other medical professional that treats prostate cancer, PLEASE stay up-to-date on the latest clinical trials that are available for your patients.

Clinical Trials Advocacy Group connects men, families, doctors, and medical professionals to information about prostate cancer clinical trials. Our goal is to create awareness, provide information and increase the options available to men. We believe that information empowers decision-making and that such an important decision, should be based on a full understanding of every available option.

Joseph D. Giglio
Executive Director

WHAT IS A CLINICAL TRIAL?

A clinical trial is a research study to test how well new treatments work in people. When doctors want to learn whether a particular cancer drug, type of surgery, radiation, or combination of treatments is better than what is currently available, they compare treatments in a clinical trial.

Featured Cancer Center

All form fields are required.

All form fields are required.















All form fields are required.